Knight Therapeutics Inc. (GUD:CA) Q1 2026 Earnings Call Transcript

May 07, 2026 12:41:24 pm

Source: SeekingAlpha

2026-05-07 12:41:24 ET

Knight Therapeutics Inc. (GUD:CA) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT

Company Participants

Samira Sakhia - President, CEO & Director
Arvind Utchanah - Chief Financial Officer
Amal Khouri - Chief Business Officer
...

For further details see:

Knight Therapeutics Inc

-1.24% G/L:

$5.89 Last:

110 Volume:

$5.89 Open:

June 05, 2026 06:00:00 pm

May 28, 2026 07:30:00 am

May 27, 2026 06:00:00 pm

May 12, 2026 06:30:00 am

Market Cap $437,402,706

Float 64,937,563

Insiders Ownership 0.03%

Institutions 86

Short Percent N/A

Industry Pharmaceuticals

Sector Healthcare

Country CA

City Saint- Laurent